<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:15:51Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5866997" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5866997</identifier>
        <datestamp>2018-03-28</datestamp>
        <setSpec>cts</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Transl Sci</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Transl Sci</journal-id>
              <journal-id journal-id-type="doi">10.1111/(ISSN)1752-8062</journal-id>
              <journal-id journal-id-type="publisher-id">CTS</journal-id>
              <journal-title-group>
                <journal-title>Clinical and Translational Science</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1752-8054</issn>
              <issn pub-type="epub">1752-8062</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5866997</article-id>
              <article-id pub-id-type="pmcid">PMC5866997</article-id>
              <article-id pub-id-type="pmc-uid">5866997</article-id>
              <article-id pub-id-type="pmid">29205871</article-id>
              <article-id pub-id-type="doi">10.1111/cts.12525</article-id>
              <article-id pub-id-type="publisher-id">CTS12525</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Articles</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Pharmacogenetic Analysis of the Model‐Based Pharmacokinetics of Five Anti‐HIV Drugs: How Does This Influence the Effect of Aging?</article-title>
                <alt-title alt-title-type="left-running-head">Chen <italic>et al</italic>.</alt-title>
                <alt-title alt-title-type="right-running-head">PGx of ATV/RTV/EFV/TFV/FTC in Aging</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="cts12525-cr-0001" contrib-type="author">
                  <name>
                    <surname>Chen</surname>
                    <given-names>Jingxian</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0002" contrib-type="author">
                  <name>
                    <surname>Akhtari</surname>
                    <given-names>Farida S.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="cts12525-aff-0003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0003" contrib-type="author">
                  <name>
                    <surname>Wagner</surname>
                    <given-names>Michael J.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0004" contrib-type="author">
                  <name>
                    <surname>Suzuki</surname>
                    <given-names>Oscar</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0005" contrib-type="author">
                  <name>
                    <surname>Wiltshire</surname>
                    <given-names>Tim</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0006" contrib-type="author">
                  <name>
                    <surname>Motsinger‐Reif</surname>
                    <given-names>Alison A.</given-names>
                  </name>
                  <xref ref-type="aff" rid="cts12525-aff-0003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="aff" rid="cts12525-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="cts12525-cr-0007" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Dumond</surname>
                    <given-names>Julie B.</given-names>
                  </name>
                  <address>
                    <email>jdumond@unc.edu</email>
                  </address>
                  <xref ref-type="aff" rid="cts12525-aff-0001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="cts12525-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">University of North Carolina Eshelman School of Pharmacy</named-content>
                <institution>University of North Carolina at Chapel Hill</institution>
                <named-content content-type="city">Chapel Hill</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cts12525-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Biological Sciences</named-content>
                <institution>North Carolina State University</institution>
                <named-content content-type="city">Raleigh</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cts12525-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Bioinformatics Research Center</named-content>
                <institution>North Carolina State University</institution>
                <named-content content-type="city">Raleigh</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cts12525-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Department of Statistics</named-content>
                <institution>North Carolina State University</institution>
                <named-content content-type="city">Raleigh</named-content>
                <named-content content-type="country-part">NC</named-content>
                <country>USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Correspondence: Julie B Dumond (<email>jdumond@unc.edu</email>)</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>03</day>
                <month>12</month>
                <year>2017</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <volume>11</volume>
              <issue>2</issue>
              <issue-id pub-id-type="doi">10.1111/cts.2018.11.issue-2</issue-id>
              <fpage>226</fpage>
              <lpage>236</lpage>
              <history>
                <date date-type="received">
                  <day>11</day>
                  <month>9</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>31</day>
                  <month>10</month>
                  <year>2017</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 ASCPT. All rights reserved <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2017 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of American Society for Clinical Pharmacology and Therapeutics</copyright-statement>
                <license license-type="creativeCommonsBy-nc">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution‐NonCommercial</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:CTS-11-226.pdf"/>
              <abstract>
                <title>Abstract</title>
                <p>Analysis of aging and pharmacogenetics (PGx) on antiretroviral pharmacokinetics (PKs) could inform precision dosing for older human HIV‐infected patients. Seventy‐four participants receiving either atazanavir/ritonavir (ATV/RTV) or efavirenz (EFV) with tenofovir/emtricitabine (TFV/FTC) provided PK and PGx information. Aging‐PGx‐PK association and interaction analyses were conducted using one‐way analysis of variance (ANOVA), multiple linear regression, and Random Forest ensemble methods. Our analyses associated unbound ATV disposition with multidrug resistance protein (MRP)4, RTV with P‐glycoprotein (P‐gp), and EFV with cytochrome P450 (CYP)2B6 and MRP4 genetic variants. The clearance and cellular distribution of TFV were associated with P‐gp, MRP2, and concentrative nucleoside transporters (CNTs), and FTC parameters were associated with organic cation transporters (OCTs) and MRP2 genetic variants. Notably, p16<sup>INK4a</sup> expression, a cellular aging marker, predicted EFV and FTC PK when genetic factors were adjusted. Both age and p16<sup>INK4a</sup> expression interacted with PGx on ATV and TFV disposition, implying potential dose adjustment based on aging may depend on genetic background.</p>
              </abstract>
              <funding-group>
                <award-group>
                  <funding-source>National Center for Advancing Translational Sciences (NCATS)</funding-source>
                  <award-id>UL1RR02574</award-id>
                </award-group>
                <award-group>
                  <funding-source>National Institutes of Health</funding-source>
                  <award-id>UL1TR001111</award-id>
                </award-group>
                <award-group>
                  <funding-source>National Institute of Allergy and Infectious Diseases</funding-source>
                  <award-id>K23 AI093156</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="0"/>
                <table-count count="6"/>
                <page-count count="11"/>
                <word-count count="7450"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>cts12525</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>March 2018</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.3.3 mode:remove_FC converted:25.03.2018</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <boxed-text position="float" content-type="box" orientation="portrait">
              <sec id="cts12525-sec-0020">
                <title>Study Highlights</title>
                <sec id="cts12525-sec-0030">
                  <title>WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?</title>
                  <p>✓ Previous studies determined an important role of aging on disposition of some ARVs. Gene polymorphisms, especially in metabolic enzymes, are related to variability in ARV PK, but their role in influencing the aging‐PK relationship is unknown.</p>
                </sec>
                <sec id="cts12525-sec-0040">
                  <title>WHAT QUESTION DID THIS STUDY ADDRESS?</title>
                  <p>✓ This study asked whether gene polymorphisms alter the interpretation of the effect of aging on (1) unbound ATV, RTV, and EFV clearance and (2) clearance and cellular distribution of TFV and FTC.</p>
                </sec>
                <sec id="cts12525-sec-0050">
                  <title>WHAT THIS STUDY ADDS TO OUR KNOWLEDGE</title>
                  <p>✓ This study updates the previous aging studies, shedding light on the significant effect of the cellular aging biomarker, p16<sup>INK4a</sup>, on unbound EFV disposition. We also present evidence of PGx‐aging interaction in ATV and TFV PKs, implying potential dose adjustment of these two drugs based on aging may be dependent on gene polymorphisms.</p>
                </sec>
                <sec id="cts12525-sec-0060">
                  <title>HOW THIS MIGHT CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE</title>
                  <p>✓ The p16<sup>INK4a</sup> might be an important biomarker to guide ATV dosing for older HIV‐infected patients. Evaluating the role of aging in dose adjustment of ATVs should take into account the presence of genetic variants in metabolic enzymes and drug transporters.</p>
                </sec>
              </sec>
            </boxed-text>
            <p>Gene polymorphisms play an important role in drug disposition and individualized therapy, as they can contribute to variability in pharmacokinetics (PKs), and may alter the effect of nongenetic factors. In HIV treatment, pharmacogenetic‐pharmacokinetic (PGx‐PK) relationships have been demonstrated for many antiretrovirals (ARVs) in the general population.<xref rid="cts12525-bib-0001" ref-type="ref">1</xref> Their roles in special populations, such as pregnancy<xref rid="cts12525-bib-0002" ref-type="ref">2</xref> and pediatrics,<xref rid="cts12525-bib-0003" ref-type="ref">3</xref> have also been evaluated. However, the PGx of ARVs in the older HIV‐infected population has not been well studied.</p>
            <p>Aging is a trend in the HIV‐infected population.<xref rid="cts12525-bib-0004" ref-type="ref">4</xref> The estimated proportion of patients aged 50 years old, which is the general definition of “older” in the HIV field, was 42% in 2013,<xref rid="cts12525-bib-0005" ref-type="ref">5</xref> and is predicted to be 70% by the end of 2035.<xref rid="cts12525-bib-0006" ref-type="ref">6</xref> Aging could change drug absorption, distribution, metabolism, and elimination,<xref rid="cts12525-bib-0007" ref-type="ref">7</xref> which could alter efficacy and safety profiles. In our previous studies, we have investigated the effects of chronological age and aging surrogates on the PK of five selected ARVs.<xref rid="cts12525-bib-0008" ref-type="ref">8</xref>, <xref rid="cts12525-bib-0009" ref-type="ref">9</xref> Our analysis showed that the clearances of two renally eliminated drugs, tenofovir (TFV) and emtricitabine (FTC), demonstrated a significant association with creatinine clearance, which is strongly related to chronological age.<xref rid="cts12525-bib-0009" ref-type="ref">9</xref> In addition, we found that the cellular clearances of their active metabolites, tenofovir diphosphate (TFV‐DP) and emtricitabine triphosphate (FTC‐TP), are associated with the expression of a cellular aging biomarker, p16<sup>INK4a</sup>.<xref rid="cts12525-bib-0009" ref-type="ref">9</xref> On the other hand, three hepatically metabolized drugs, atazanavir (ATV), ritonavir (RTV), and efavirenz (EFV), did not show statistically significant relationships with aging, in either total or unbound drug disposition,<xref rid="cts12525-bib-0008" ref-type="ref">8</xref> although the sample size for these drugs was smaller than that of TFV/FTC.</p>
            <p>Identification of influential single‐nucleotide polymorphisms (SNPs) could provide PGx information for ARV dosing adjustment, and improve statistical analyses of aging by reducing variability in PK. Additionally, gene polymorphisms can modify the effect of aging on PK, and evidence for such interactions has been shown for non‐ARV drugs. For example, less profound changes in systemic clearance of omeprazole between younger and older patients was observed in cytochrome P450 (CYP)2C19 poor metabolizers than in extensive metabolizers.<xref rid="cts12525-bib-0010" ref-type="ref">10</xref> This implies that dose adjustment in older patients might be less important given the dysfunctional CYP2C19 genotype. In another example, an eightfold increase in the mean dose‐adjusted plasma concentration of venlafaxine was seen in older compared with younger patients among the CYP2D6 poor metabolizers, but not in the other genotype groups.<xref rid="cts12525-bib-0010" ref-type="ref">10</xref> This suggests that dose adjustment might be necessary in the presence of CYP2D6 dysfunction. Therefore, investigating aging in the context of PGx or aging‐PGx interaction is essential to provide precise treatment for older patients.</p>
            <p>In addition to the aging‐PK associations, as outlined in our previous publications, our studied drugs also serve as reasonable models for aging‐PGx‐PK investigation, because their disposition profiles cover a broad spectrum of metabolic enzymes and drug transporters. ATV and RTV are CYP3A substrates,<xref rid="cts12525-bib-0011" ref-type="ref">11</xref>, <xref rid="cts12525-bib-0012" ref-type="ref">12</xref> and served as two model drugs to probe these enzymes. In addition, the upstream CYP3A expression regulator, pregnane X receptor (PXR), affects ATV clearance.<xref rid="cts12525-bib-0013" ref-type="ref">13</xref>, <xref rid="cts12525-bib-0014" ref-type="ref">14</xref> Uridine 5′‐diphosphate glucuronosyltransferase (UGT)1A is responsible for ATV glucuronidation and is inhibited by ATV.<xref rid="cts12525-bib-0011" ref-type="ref">11</xref> EFV has a complex metabolic profile, which involves CYP2B, CYP2A, CYP3A, CYP1A, and UGT.<xref rid="cts12525-bib-0015" ref-type="ref">15</xref> It is also an inducer or inhibitor of CYP2B, CYP3A, and CYP2C.<xref rid="cts12525-bib-0016" ref-type="ref">16</xref> Transporters in the gut, such as P‐glycoprotein (P‐gp) and multidrug resistance proteins (MRPs), are presumably important globally to ARVs, which are mostly orally administrated.<xref rid="cts12525-bib-0001" ref-type="ref">1</xref> Organic anion‐transporting polypeptides (OATPs), which are enriched in the liver, could be relevant to ATV, RTV, and EFV, and OATs or organic cation transporters (OCTs) in the kidney are important to TFV or FTC.<xref rid="cts12525-bib-0017" ref-type="ref">17</xref> Nucleoside transporters, concentrative nucleoside transporters (CNTs) and equilibrative nucleoside transporters, are believed to transport nucleoside analogs,<xref rid="cts12525-bib-0001" ref-type="ref">1</xref>, <xref rid="cts12525-bib-0017" ref-type="ref">17</xref> which could be crucial to the disposition of TFV and FTC and the cellular accumulation of their active metabolites.</p>
            <p>In the current study, we aim to re‐evaluate the effect of aging on PK on five studied drugs in the context of PGx and investigate the aging‐PGx interaction in PK. Using a candidate gene approach to select important SNPs, we also aim to provide new hypotheses for further PGx investigations of ARVs. For phenotype, we have focused on the clearance of TFV, FTC and unbound ATV, RTV and EFV, as well as cellular clearance of TFV‐DP and FTC‐TP, using the associated individual parameters derived from the previous established population PK models.</p>
            <sec id="cts12525-sec-0070">
              <title>MATERIALS AND METHODS</title>
              <sec id="cts12525-sec-0080">
                <title>Clinical trial</title>
                <p>Study conduct has been described in previous publications.<xref rid="cts12525-bib-0008" ref-type="ref">8</xref>, <xref rid="cts12525-bib-0009" ref-type="ref">9</xref> Briefly, HIV‐infected patients were enrolled from the University of North Carolina HealthCare Infectious Diseases Clinic (Chapel Hill, NC) and the Cone Health Regional Center for Infectious Diseases (Greensboro, NC). All the subjects received steady‐state tenofovir disoproxil fumarate (TDG)/FTC 300/200 mg with either EFV 600 mg or ATV/RTV 300/200 mg daily. Blood samples were collected either sparsely at four time points (predose, and then 2 h, 4–6 h, and 10–14 h postdose) or intensively at 11 time points for PK analysis. An extra blood sample was collected for those who consented to be involved into the PGx analysis. The study protocol was approved by the institutional review boards of both institutions (Clinicaltrials.gov NCT01180075).</p>
              </sec>
              <sec id="cts12525-sec-0090">
                <title>Genotyping</title>
                <p>Samples for this test were obtained from patients who consented to genotyping assays at screening. Genomic DNA was extracted from whole blood using QIAamp DNA Blood Mini Kit (QIAGEN). Genotyping was conducted for selected metabolic enzymes and drug transporters using DMET Plus microarray (Affymetrix, CA). Samples with a call rate &lt;95% were excluded from analysis. The SNPs were excluded if its minor allele frequency was &lt;4% and its missing genotypes were &gt;30%. Deviations from expected proportions based on Hardy‐Weinberg equilibrium (exact test, α &gt; 0.05) and linkage disequilibrium (R<sup>2</sup> &gt; 0.2) analysis were performed in PLINK software version 1.07.<xref rid="cts12525-bib-0018" ref-type="ref">18</xref>
</p>
              </sec>
              <sec id="cts12525-sec-0100">
                <title>Phenotypes</title>
                <p>The phenotypes in this study were the post hoc PK parameters. The PK analysis was performed as previously described.<xref rid="cts12525-bib-0008" ref-type="ref">8</xref>, <xref rid="cts12525-bib-0009" ref-type="ref">9</xref> Briefly, drug concentrations were measured in the University of North Carolina Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Laboratory. Total and intracellular drug concentrations were measured by validated liquid‐chromatography tandem mass spectrometry. Unbound EFV, ATV, and RTV concentrations were analyzed using rapid equilibrium dialysis followed by liquid‐chromatography tandem mass spectrometry. Population PK models were developed for each drug using nonlinear mixed effects modeling program NONMEM version 7.3 (ICON Development Solutions, Hanover, MD). For the current study, individual PK parameters of interest included clearance of the unbound drug for EFV, ATV, and RTV, clearance of the parent drug for TFV and FTC, and the rate constant of intracellular metabolite conversion and elimination for TFV‐DP and FTC‐TP. These estimates were obtained using the Bayesian post hoc estimation method based on the final models, including the covariate effects of creatinine clearance on TFV and FTC clearance and p16<sup>INK4a</sup> expression on TFV‐DP and FTC‐TP disposition.</p>
              </sec>
              <sec id="cts12525-sec-0110">
                <title>Statistical analysis</title>
                <p>A candidate gene approach was used to perform this analysis. The candidate genes were chosen if shown to be relevant to studied drug disposition pathways. Variables were log‐transformed to achieve normality when appropriate. In the univariate analysis, the association analysis between genotypes and PK parameters was conducted using one‐way analysis of variance (ANOVA). Then, SNPs with a nominally significant <italic>P</italic> value were included in multivariate analysis using the stepwise selection procedure in both forward and backward directions. Model selection was based on Akaike information criteria, involving demographic covariates of interest, including chronological age, p16<sup>INK4a</sup> expression level, race, sex, and body mass index (BMI). Missing genotypes were imputed using IMPUTE2 with the 1000 Genomes Phase III panel.<xref rid="cts12525-bib-0019" ref-type="ref">19</xref>, <xref rid="cts12525-bib-0020" ref-type="ref">20</xref> For race, patients who were other, unknown, and nonreported races were grouped as one category (“others”) due to low counts. Additionally, the effect of creatinine clearance and treatment arms were evaluated for TFV and FTC. Comparison of demographics between two treatment arms was conducted using Mann‐Whitney U test or Kruskal‐Wallis test. These statistical analyses were performed using R version 3.2 (R‐project.org). A <italic>P</italic> value &lt; 0.05 was considered statistically significant.</p>
                <p>To investigate the interaction between aging and gene polymorphism, we used distinct linear regression models (R function <italic>lm</italic>, package stats version 3.4.0; <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">www.r-project.org</ext-link>)<xref rid="cts12525-bib-0021" ref-type="ref">21</xref> to determine if there is an effect on drug clearance due to the interaction between chronological age and gene polymorphisms (SNPs), and between p16<sup>INK4a</sup> expression and gene polymorphisms. An F‐test (R function ANOVA, package stats version 3.4.0)<xref rid="cts12525-bib-0021" ref-type="ref">21</xref> was used to compare the model without interaction effects to the one with interaction effects. Only significant predictors from the best fitting model were retained in the final model, with the cutoff for significance being <italic>P</italic> &lt; 0.05 for each predictor. The factors involved in each interaction effect were always included in the model. Multiple testing corrections were performed across all drugs using the Benjamini‐Hochberg method with a false discovery rate of q &lt; 0.1 (R function p.adjust, package stats version 3.4.0).<xref rid="cts12525-bib-0021" ref-type="ref">21</xref>
</p>
                <p>In order to determine variable interactions and variable importance of all available variables, we used the Random Forest ensemble method (R function randomForest(ntree = 5000), package randomForest version 4.6‐12)<xref rid="cts12525-bib-0022" ref-type="ref">22</xref> for each drug, with the PK parameter as the response, after removing all incomplete cases. We used the percent increase in mean squared error to determine the three most important predictors for each drug.</p>
                <p>The effects of significant SNPs on corresponding proteins were evaluated based on literature and database (e.g., dbSNP, PharmGKB) searching. The SIFT and PolyPhen algorithms were used to make predictions for SNPs with no current information on how they influence the protein. If still no information is available, those SNPs in linkage disequilibrium with r<sup>2</sup> &gt;0.8 were also investigated. Protein function prediction was conducted using SNPnexus.<xref rid="cts12525-bib-0023" ref-type="ref">23</xref>, <xref rid="cts12525-bib-0024" ref-type="ref">24</xref>, <xref rid="cts12525-bib-0025" ref-type="ref">25</xref> Linked SNPs were obtained through HaploReg version 4.1.<xref rid="cts12525-bib-0026" ref-type="ref">26</xref>
</p>
              </sec>
            </sec>
            <sec id="cts12525-sec-0120">
              <title>RESULTS</title>
              <sec id="cts12525-sec-0130">
                <title>Population</title>
                <p>In 91 patients enrolled in the original clinical study, 74 consented to the genetic tests; 25 were in the ATV/RTV/TFC/FTC arm and 49 in the EFV/TFV/FTC arm. The median age of the 74 patients was 48 years. The self‐reported race includes the following categories: white (24/74); Black/African American (45/74); other (3/74); unknown (1/74), and not reported (1/74). Fifty‐two percent of the patients were men. Three patients demonstrated the Fried frailty phenotype.<xref rid="cts12525-bib-0027" ref-type="ref">27</xref> The characteristics between the two treatment arms were not significantly different. The studied PK parameters included apparent unbound drug clearance (CL<sub>u</sub>/F) of ATV, RTV, and EFV, apparent clearance (CL/F) of TFV and FTC, and clearance of TFV and FTC metabolites (TFV‐DP and FTC‐TP, respectively) into (CL<sub>in</sub>) and out of (CL<sub>out</sub>) of peripheral blood mononuclear cells. In total, 22 genes were selected for investigation. Patient demographics, PK parameters, and studied genes and SNPs are summarized in <bold>Table</bold>
<xref rid="cts12525-tbl-0001" ref-type="table-wrap">1</xref>.</p>
                <table-wrap id="cts12525-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Overview of demographics of studied population and the pharmacokinetics and pharmacogenetics of the studied drugs</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                        <th align="center" rowspan="1" colspan="1">ATV</th>
                        <th align="center" rowspan="1" colspan="1">RTV</th>
                        <th align="center" rowspan="1" colspan="1">EFV</th>
                        <th align="center" rowspan="1" colspan="1">TFV</th>
                        <th align="center" rowspan="1" colspan="1">FTC</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>No. of subjects</bold>
                        </td>
                        <td colspan="2" align="center" rowspan="1">25</td>
                        <td align="center" rowspan="1" colspan="1">49</td>
                        <td colspan="2" align="center" rowspan="1">74</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>Age (years)</bold>
                        </td>
                        <td colspan="2" align="center" rowspan="1">49 (24, 61)</td>
                        <td align="center" rowspan="1" colspan="1">48 (22, 73)</td>
                        <td colspan="2" align="center" rowspan="1">48 (22, 73)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Race</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">African</td>
                        <td colspan="2" align="center" rowspan="1">15 (60%)</td>
                        <td align="center" rowspan="1" colspan="1">30 (61%)</td>
                        <td colspan="2" align="center" rowspan="1">45 (61%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">American</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">White</td>
                        <td colspan="2" align="center" rowspan="1">8 (32%)</td>
                        <td align="center" rowspan="1" colspan="1">16 (33%)</td>
                        <td colspan="2" align="center" rowspan="1">24 (32%)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Others</td>
                        <td colspan="2" align="center" rowspan="1">2 (8%)</td>
                        <td align="center" rowspan="1" colspan="1">3 (6%)</td>
                        <td colspan="2" align="center" rowspan="1">5 (7%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Female</td>
                        <td colspan="2" align="center" rowspan="1">10 (40%)</td>
                        <td align="center" rowspan="1" colspan="1">12 (24%)</td>
                        <td colspan="2" align="center" rowspan="1">22 (30%)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Male</td>
                        <td colspan="2" align="center" rowspan="1">15 (60%)</td>
                        <td align="center" rowspan="1" colspan="1">37 (76%)</td>
                        <td colspan="2" align="center" rowspan="1">52 (70%)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>CrCL (L/h)</bold>
                        </td>
                        <td colspan="2" align="center" rowspan="1">96.6 (66.8, 228)</td>
                        <td align="center" rowspan="1" colspan="1">112 (43.3, 200)</td>
                        <td colspan="2" align="center" rowspan="1">109 (43.3, 228)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>BMI (kg/m<sup>2</sup>)</bold>
                        </td>
                        <td colspan="2" align="center" rowspan="1">29.8 (20.2, 40.4)</td>
                        <td align="center" rowspan="1" colspan="1">27.1 (17.6, 44.3)</td>
                        <td colspan="2" align="center" rowspan="1">28.6 (17.6, 44.3)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Frailty status</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Nonfrail</td>
                        <td colspan="2" align="center" rowspan="1">16 (64%)</td>
                        <td align="center" rowspan="1" colspan="1">37 (76%)</td>
                        <td colspan="2" align="center" rowspan="1">53 (72%)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Pre‐frail</td>
                        <td colspan="2" align="center" rowspan="1">8 (32%)</td>
                        <td align="center" rowspan="1" colspan="1">10 (20%)</td>
                        <td colspan="2" align="center" rowspan="1">18 (24%)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Frail</td>
                        <td colspan="2" align="center" rowspan="1">1 (4%)</td>
                        <td align="center" rowspan="1" colspan="1">2 (4%)</td>
                        <td colspan="2" align="center" rowspan="1">3 (4%)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>p16<sup>INK4a</sup> expression</bold>
                          <xref ref-type="fn" rid="cts12525-tbl1-note-0001">a</xref>
                        </td>
                        <td colspan="2" align="center" rowspan="1">2.20 (0.158, 3.91)</td>
                        <td align="center" rowspan="1" colspan="1">1.92 (‐1.14, 2.81)</td>
                        <td colspan="2" align="center" rowspan="1">2.01 (‐1.14, 3.91)</td>
                      </tr>
                    </tbody>
                  </table>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr>
                        <th colspan="2" align="left" rowspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1">TFV CL/F: 46.8 (16.6, 115)</th>
                        <th align="center" rowspan="1" colspan="1">FTC CL/F: 17.9 (4.54, 27.4)</th>
                      </tr>
                      <tr>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th colspan="2" style="border-bottom:solid 1px #000000" align="center" rowspan="1"/>
                      </tr>
                      <tr>
                        <th colspan="2" align="left" rowspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th align="center" rowspan="1" colspan="1"/>
                        <th style="border-bottom:solid 1px #000000" align="center" rowspan="1" colspan="1">TFV‐DP CL<sub>in</sub>: 0.00235 (0.000814, 0.00874)</th>
                        <th align="center" rowspan="1" colspan="1">‐</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000" valign="bottom">
                        <th colspan="2" align="left" valign="bottom" rowspan="1">PK parameters and medians (ranges)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CL<sub>u</sub>/F: 93.6 (18.2, 355)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CL<sub>u</sub>/F: 965 (69.5, 2380)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">CL<sub>u</sub>/F: 1010 (417, 3280)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">TFV‐DP CL<sub>out</sub>: 0.00214 (0.000869, 0.00511)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">FTC‐TP CL<sub>out</sub>: 0.0292 (0.0978, 0.141)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr style="border-bottom:solid 1px #000000">
                        <td colspan="2" align="left" rowspan="1">
                          <bold>No. of SNPs</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">40</td>
                        <td align="center" rowspan="1" colspan="1">37</td>
                        <td align="center" rowspan="1" colspan="1">44</td>
                        <td align="center" rowspan="1" colspan="1">52</td>
                        <td align="center" rowspan="1" colspan="1">60</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Studied genes</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Genes for metabolic enzymes</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>PXR</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>PXR</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>PXR</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>‐</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>‐</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP2C9</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP1A2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP2A6</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP2B6</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP2B6</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A5</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>UGT1A1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A5</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A5</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>CYP3A7</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>UGT2B7</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="6" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Genes for drug transporters</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCB1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCB1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCB1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCB1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC1</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLCO1B1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC2</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLCO1B1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLCO1B3</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC4</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC3</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCG2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC4</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A11</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCC5</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>ABCG2</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A7</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A2</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A8</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC22A3</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC28A1</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC28A1</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC28A2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC28A2</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SCL28A3</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC28A3</italic>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC29A2</italic>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <italic>SLC29A2</italic>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl1-note-0001">
                      <p>ATV, atazanavir; BMI, body mass index; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CL<sub>u</sub>/F, apparent unbound drug clearance; CrCL, creatinine clearance; CYP, cytochrome P450; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; PK, pharmacokinetic; PXR, pregnane X receptor; RTV, ritonavir; SNP, single‐nucleotide polymorphism; TFV, tenofovir; TFV‐DP, tenofovir diphosphate; UGT, uridine 5′‐diphosphate glucuronosyltransferase.</p>
                    </fn>
                    <fn id="cts12525-tbl1-note-0002">
                      <p>Clearance is in liter/hour (L/h).</p>
                    </fn>
                    <fn id="cts12525-tbl1-note-0003">
                      <p><sup>a</sup>The expression of p16<sup>INK4a</sup> is presented as logarithm (base 2) of gene expression. Continuous variables are in median (range). Categorical variables are in count (percentage).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="cts12525-sec-0140">
                <title>Linear regression analysis</title>
                <p>The <italic>P</italic> values for univariate analysis are shown in <bold>Table</bold>
<xref rid="cts12525-tbl-0002" ref-type="table-wrap">2</xref>. Twenty‐one SNPs were found to be significantly associated with the PK parameters. The SNP basic information, genotype frequency, effects on phenotypes, and SNP function are summarized in <bold>Table</bold>
<xref rid="cts12525-tbl-0003" ref-type="table-wrap">3</xref>.<xref rid="cts12525-bib-0015" ref-type="ref">15</xref>, <xref rid="cts12525-bib-0028" ref-type="ref">28</xref>, <xref rid="cts12525-bib-0029" ref-type="ref">29</xref>, <xref rid="cts12525-bib-0030" ref-type="ref">30</xref>, <xref rid="cts12525-bib-0031" ref-type="ref">31</xref> No significant SNPs were found for the TFV‐DP CL<sub>out</sub>. The FTC‐TP CL<sub>in</sub> showed the same statistical results as the FTC CL/F, because during the model construction the FTC‐TP CL<sub>in</sub> was described as a fixed fraction of FTC CL/F.<xref rid="cts12525-bib-0009" ref-type="ref">9</xref> Therefore, TFV‐DP CL<sub>out</sub> and FTC‐TP CL<sub>in</sub> were excluded from further analysis. Associations between demographics and PK parameters were consistent with the previous population PK analysis. Briefly, BMI was associated with RTV clearance. Age and creatinine clearance were correlated, and shown to be related to CL/F of both TFV and FTC. The p16<sup>INK4a</sup> expression was associated with FTC CL/F and FTC CL<sub>out</sub>.</p>
                <table-wrap id="cts12525-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 2</label>
                  <caption>
                    <p>The <italic>P</italic> values in the univariate analysis</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Factors</th>
                        <th align="center" rowspan="1" colspan="1">ATV CL<sub>u</sub>/F</th>
                        <th align="center" rowspan="1" colspan="1">RTV CL<sub>u</sub>/F</th>
                        <th align="center" rowspan="1" colspan="1">EFV CL<sub>u</sub>/F</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.74</td>
                        <td align="center" rowspan="1" colspan="1">0.64</td>
                        <td align="center" rowspan="1" colspan="1">0.55</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>p16 expression</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.20</td>
                        <td align="center" rowspan="1" colspan="1">0.43</td>
                        <td align="center" rowspan="1" colspan="1">0.57</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Race</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.40</td>
                        <td align="center" rowspan="1" colspan="1">0.95</td>
                        <td align="center" rowspan="1" colspan="1">0.22</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>BMI</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.66</td>
                        <td align="center" rowspan="1" colspan="1">0.025<xref ref-type="fn" rid="cts12525-tbl2-note-0002">*</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0.64</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.10</td>
                        <td align="center" rowspan="1" colspan="1">0.75</td>
                        <td align="center" rowspan="1" colspan="1">0.07</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Frailty status</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.074</td>
                        <td align="center" rowspan="1" colspan="1">0.21</td>
                        <td align="center" rowspan="1" colspan="1">0.69</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>CrCL</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Treatment arm</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                        <td align="center" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>SNP</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0001">
                            <list-item>
                              <p><italic>SLCO1B1</italic>_c.571T&gt;C: 0.036</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC4</italic>_c.<sup>*</sup>879T&gt;C: 0.040</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0002">
                            <list-item>
                              <p><italic>ABCB1</italic>_c.3435C&gt;T: 0.0021</p>
                            </list-item>
                            <list-item>
                              <p><italic>CYP1A2</italic><sup>*</sup><italic>1C</italic>_‐3860G&gt;A: 0.011</p>
                            </list-item>
                            <list-item>
                              <p><italic>CYP2B6</italic>_14593C&gt;G: 0.047</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0003">
                            <list-item>
                              <p><italic>CYP2B6</italic><sup>*</sup><italic>6</italic>_15631G&gt;T: 0.00025</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC4</italic>_c.3348A&gt;G/Del: 0.0056</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC4</italic>_c. <sup>*</sup>311G&gt;A: 0.0055</p>
                            </list-item>
                            <list-item>
                              <p><italic>CYP2B6</italic><sup>*</sup><italic>4</italic>_18053A&gt;G(K262R): 0.013</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC4</italic>_c. <sup>*</sup>38T&gt;G: 0.013</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">Factors</th>
                        <th align="center" rowspan="1" colspan="1">TFV CL/F</th>
                        <th align="center" rowspan="1" colspan="1">TFV‐DP CL<sub>in</sub>
</th>
                        <th align="center" rowspan="1" colspan="1">FTC CL/F</th>
                        <th align="center" rowspan="1" colspan="1">FTC‐TP CL<sub>out</sub>
</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl2-note-0002">***</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0.43</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl2-note-0002">***</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0.50</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>p16 expression</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.78</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                        <td align="center" rowspan="1" colspan="1">0.020<xref ref-type="fn" rid="cts12525-tbl2-note-0002">*</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl2-note-0002">***</xref>
</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Race</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.34</td>
                        <td align="center" rowspan="1" colspan="1">0.49</td>
                        <td align="center" rowspan="1" colspan="1">0.14</td>
                        <td align="center" rowspan="1" colspan="1">0.47</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>BMI</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.11</td>
                        <td align="center" rowspan="1" colspan="1">0.26</td>
                        <td align="center" rowspan="1" colspan="1">0.19</td>
                        <td align="center" rowspan="1" colspan="1">0.83</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.20</td>
                        <td align="center" rowspan="1" colspan="1">0.17</td>
                        <td align="center" rowspan="1" colspan="1">0.54</td>
                        <td align="center" rowspan="1" colspan="1">0.23</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Frailty status</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.58</td>
                        <td align="center" rowspan="1" colspan="1">0.30</td>
                        <td align="center" rowspan="1" colspan="1">0.11</td>
                        <td align="center" rowspan="1" colspan="1">0.22</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>CrCL</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl2-note-0002">***</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0.28</td>
                        <td align="center" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl2-note-0002">***</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">0.63</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Treatment arm</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">0.11</td>
                        <td align="center" rowspan="1" colspan="1">0.28</td>
                        <td align="center" rowspan="1" colspan="1">0.15</td>
                        <td align="center" rowspan="1" colspan="1">0.86</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>SNP</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0004">
                            <list-item>
                              <p><italic>ABCB1</italic>_c.‐129T&gt;C: 0.013</p>
                            </list-item>
                            <list-item>
                              <p><italic>SLC28A1</italic>_c.1561G&gt;A: 0.015</p>
                            </list-item>
                            <list-item>
                              <p><italic>SLC28A2</italic>_c.531T&gt;C: 0.0060</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0005">
                            <list-item>
                              <p><italic>ABCB1</italic>_c.1725+38A&gt;G: 0.0064</p>
                            </list-item>
                            <list-item>
                              <p><italic>SLC28A2</italic>_c.734G&gt;C: 0.0090</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC2</italic>_c.3563T&gt;A: 0.038</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0006">
                            <list-item>
                              <p><italic>SLC22A3</italic>_c.360C&gt;T&gt;G: 0.032</p>
                            </list-item>
                            <list-item>
                              <p><italic>SLC22A2</italic>_c.1506G&gt;A: 0.018</p>
                            </list-item>
                            <list-item>
                              <p><italic>ABCC2</italic>_c.4488C&gt;T: 0.020</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0007">
                            <list-item>
                              <p><italic>ABCC2</italic>_c.1249G&gt;A: 0.0046</p>
                            </list-item>
                            <list-item>
                              <p><italic>SLC28A1</italic>_c.1149A&gt;G: 0.038</p>
                            </list-item>
                          </list>
                        </td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl2-note-0001">
                      <p>ATV, atazanavir; BMI, body mass index; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CL<sub>u</sub>/F, apparent unbound drug clearance; CrCL, creatinine clearance; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; RTV, ritonavir; SNP, single‐nucleotide polymorphism; TFV, tenofovir; TFV‐DP, tenofovir diphosphate.</p>
                    </fn>
                    <fn id="cts12525-tbl2-note-0002">
                      <p><sup>*</sup><italic>P</italic> &lt; 0.05; <sup>***</sup>
<italic>P</italic> &lt; 0.001.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <table-wrap id="cts12525-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Summary of the SNPs showing statistical significance in the univariate analysis</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000" valign="bottom">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Studied drug</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>dbSNP RS</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Associated gene/protein</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"><bold>c</bold>.</th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Base change</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Function</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Genotype frequency</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Phenotype</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Previously reported phenotype</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Physiological reasonable?</bold>
                        </th>
                        <th align="left" valign="bottom" rowspan="1" colspan="1">
                          <bold>Physiological reason</bold>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>ATV</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs1059751</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>/MRP4</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">879T&gt;C</td>
                        <td align="left" rowspan="1" colspan="1">3'‐UTR</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0008">
                            <list-item>
                              <p>T/T+T/C: 23 (92%)</p>
                            </list-item>
                            <list-item>
                              <p>C/C: 2 (8%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased efflux from liver to system</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs4149057</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLCO1B1</italic>/OATP1B1</td>
                        <td align="left" rowspan="1" colspan="1">12</td>
                        <td align="left" rowspan="1" colspan="1">571T&gt;C</td>
                        <td align="left" rowspan="1" colspan="1">L191L</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0009">
                            <list-item>
                              <p>T/T+T/C: 21 (84%)</p>
                            </list-item>
                            <list-item>
                              <p>C/C: 4 (16%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>RTV</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs1045642</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>/P‐gp</td>
                        <td align="left" rowspan="1" colspan="1">7</td>
                        <td align="left" rowspan="1" colspan="1">3435C&gt;T</td>
                        <td align="left" rowspan="1" colspan="1">I1145I</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0010">
                            <list-item>
                              <p>C/C: 14 (56%)</p>
                            </list-item>
                            <list-item>
                              <p>C/T+T/T: 11 (44%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased expression</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased bioavailability</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs2069514</td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP1A2</italic>/CYP1A2</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">‐3860G&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">Promoter</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0011">
                            <list-item>
                              <p>G/G+G/A: 22 (88%)</p>
                            </list-item>
                            <list-item>
                              <p>A/A: 3 (12%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">1C,<xref ref-type="fn" rid="cts12525-tbl3-note-0002">a</xref> decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased metabolism</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs4803418</td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6</italic>/CYP2B6</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">14593C&gt;G</td>
                        <td align="left" rowspan="1" colspan="1">Intronic</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0012">
                            <list-item>
                              <p>C/C: 19 (76%)</p>
                            </list-item>
                            <list-item>
                              <p>C/G: 6 (24%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">1C,<xref ref-type="fn" rid="cts12525-tbl3-note-0002">a</xref> increased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased metabolism</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>EFV</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs3745274<xref ref-type="fn" rid="cts12525-tbl3-note-0003">b</xref>
</td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6</italic>/CYP2B6</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">15631G&gt;T</td>
                        <td align="left" rowspan="1" colspan="1">Q172H</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0013">
                            <list-item>
                              <p>G/G+G/T: 41 (84%)</p>
                            </list-item>
                            <list-item>
                              <p>T/T: 6 (12%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 2 (4%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">6,<xref ref-type="fn" rid="cts12525-tbl3-note-0002">a</xref> decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased metabolism</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs2279343</td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6</italic>/CYP2B6</td>
                        <td align="left" rowspan="1" colspan="1">19</td>
                        <td align="left" rowspan="1" colspan="1">18053A&gt;G</td>
                        <td align="left" rowspan="1" colspan="1">K262R</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0014">
                            <list-item>
                              <p>A/A+A/G: 39 (80%)</p>
                            </list-item>
                            <list-item>
                              <p>G/G: 7 (14%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 3 (6%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">4,<xref ref-type="fn" rid="cts12525-tbl3-note-0002">a</xref> decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased metabolism</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs1751034</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>/MRP4</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">3348A&gt;G/Del</td>
                        <td align="left" rowspan="1" colspan="1">K1116K/X</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0015">
                            <list-item>
                              <p>A/A+A/G: 45 (92%)</p>
                            </list-item>
                            <list-item>
                              <p>G/G: 4 (8%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased bioavailability</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs4148551</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>/MRP4</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">311G&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">3’‐UTR</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0016">
                            <list-item>
                              <p>G/G: 11 (22%)</p>
                            </list-item>
                            <list-item>
                              <p>G/A+A/A: 38 (78%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs3742106</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>/MRP4</td>
                        <td align="left" rowspan="1" colspan="1">13</td>
                        <td align="left" rowspan="1" colspan="1">38T&gt;G</td>
                        <td align="left" rowspan="1" colspan="1">3’‐UTR</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0017">
                            <list-item>
                              <p>T/T+T/G: 46 (94%)</p>
                            </list-item>
                            <list-item>
                              <p>G/G: 3 (6%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased bioavailability</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs3213619</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>/P‐gp</td>
                        <td align="left" rowspan="1" colspan="1">7</td>
                        <td align="left" rowspan="1" colspan="1">‐129T&gt;C</td>
                        <td align="left" rowspan="1" colspan="1">5’‐UTR</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0018">
                            <list-item>
                              <p>T/T: 61 (82%)</p>
                            </list-item>
                            <list-item>
                              <p>T/C: 13 (18%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased bioavailability</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs2242046</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>/CNT1</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">1561G&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">D521N</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0019">
                            <list-item>
                              <p>G/G: 49 (66%)</p>
                            </list-item>
                            <list-item>
                              <p>G/A+A/A: 19 (26%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 6 (8%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Increased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased renal excretion</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs8023604</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>/CNT2</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">531T&gt;C</td>
                        <td align="left" rowspan="1" colspan="1">F177F</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0020">
                            <list-item>
                              <p>T/T+T/C: 58 (79%)</p>
                            </list-item>
                            <list-item>
                              <p>C/C: 15 (20%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 1 (1%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV‐DP</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs2235013</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>/P‐gp</td>
                        <td align="left" rowspan="1" colspan="1">7</td>
                        <td align="left" rowspan="1" colspan="1">1725+38G&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">Intronic</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0021">
                            <list-item>
                              <p>G/G: 24 (27%)</p>
                            </list-item>
                            <list-item>
                              <p>G/A+A/A: 50 (73%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↓ CL<sub>in</sub>
</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs10519020</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>/CNT2</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">734G&gt;C</td>
                        <td align="left" rowspan="1" colspan="1">S245T</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0022">
                            <list-item>
                              <p>G/G+G/C: 72 (97%)</p>
                            </list-item>
                            <list-item>
                              <p>C/C: 2 (3%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL<sub>in</sub>
</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">N<xref ref-type="fn" rid="cts12525-tbl3-note-0002">a</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Presumably decreased cellular uptake</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs17222723</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>/MRP2</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                        <td align="left" rowspan="1" colspan="1">3563T&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">V1188E</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0023">
                            <list-item>
                              <p>T/T: 64 (86%)</p>
                            </list-item>
                            <list-item>
                              <p>T/A: 10 (14%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL<sup>in</sup>
</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function<xref ref-type="fn" rid="cts12525-tbl3-note-0004">c</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Decreased efflux</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs668871</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A3</italic>/OCT3</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">360C&gt;T/G</td>
                        <td align="left" rowspan="1" colspan="1">R120R</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0024">
                            <list-item>
                              <p>C/C: 14 (19%)</p>
                            </list-item>
                            <list-item>
                              <p>C/T+T/T: 57 (77%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 3 (4%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Increased expression<xref ref-type="fn" rid="cts12525-tbl3-note-0005">d</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased renal excretion</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs316003</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A2</italic>/OCT2</td>
                        <td align="left" rowspan="1" colspan="1">6</td>
                        <td align="left" rowspan="1" colspan="1">1506A&gt;G</td>
                        <td align="left" rowspan="1" colspan="1">V502V</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0025">
                            <list-item>
                              <p>A/A+A/G: 60 (81%)</p>
                            </list-item>
                            <list-item>
                              <p>G/G: 14 (19%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 1 (1%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs8187707</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>/MRP2</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                        <td align="left" rowspan="1" colspan="1">4488C&gt;T</td>
                        <td align="left" rowspan="1" colspan="1">H1496H</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0026">
                            <list-item>
                              <p>C/C: 67 (91%)</p>
                            </list-item>
                            <list-item>
                              <p>C/T: 7 (8%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL/F</td>
                        <td align="left" rowspan="1" colspan="1">Decreased function<xref ref-type="fn" rid="cts12525-tbl3-note-0004">c</xref>
</td>
                        <td align="left" rowspan="1" colspan="1">N</td>
                        <td align="left" rowspan="1" colspan="1">Presumably decreased renal excretion or increased bioavailability</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC‐TP</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">rs2273697</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>/MRP2</td>
                        <td align="left" rowspan="1" colspan="1">10</td>
                        <td align="left" rowspan="1" colspan="1">1249G&gt;A</td>
                        <td align="left" rowspan="1" colspan="1">V417I</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0027">
                            <list-item>
                              <p>G/G: 45 (61%)</p>
                            </list-item>
                            <list-item>
                              <p>G/A+A/A: 29 (39%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL<sub>out</sub>/F</td>
                        <td align="left" rowspan="1" colspan="1">Increased function</td>
                        <td align="left" rowspan="1" colspan="1">Y</td>
                        <td align="left" rowspan="1" colspan="1">Increased efflux</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="10" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">rs2305367</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>/CNT1</td>
                        <td align="left" rowspan="1" colspan="1">15</td>
                        <td align="left" rowspan="1" colspan="1">1149A&gt;G</td>
                        <td align="left" rowspan="1" colspan="1">K383K</td>
                        <td align="left" rowspan="1" colspan="1">
                          <list list-type="simple" id="cts12525-list-0028">
                            <list-item>
                              <p>A/A+A/G: 44 (60%)</p>
                            </list-item>
                            <list-item>
                              <p>G/G: 27 (36%)</p>
                            </list-item>
                            <list-item>
                              <p>Missing: 3 (4%)</p>
                            </list-item>
                          </list>
                        </td>
                        <td align="left" rowspan="1" colspan="1">↑ CL<sub>out</sub>/F</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                        <td align="left" rowspan="1" colspan="1">–</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl3-note-0001">
                      <p>ATV, atazanavir; c., chromosome number; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CNT, concentrative nucleoside transporter; CYP, cytochrome P450; dbSNP, database‐single‐nucleotide polymorphism; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; MRP, multidrug resistance protein; OATP, organic anion‐transporting polypeptide; P‐gp, P‐glycoprotein; RS, reference single‐nucleotide polymorphism cluster ID; SNP, single‐nucleotide polymorphism; TFV, tenofovir; TFV‐DP, tenofovir diphosphate; UTR, untranslated region.</p>
                    </fn>
                    <fn id="cts12525-tbl3-note-0002">
                      <label>a</label>
                      <p>The finding is inconsistent with the predicted phenotypic effects.</p>
                    </fn>
                    <fn id="cts12525-tbl3-note-0003">
                      <label>b</label>
                      <p>The rs8187710 (r<sup>2</sup> = 0.98 with rs17222723 and rs8187707) was shown to decrease MRP2 function (ref. <xref rid="cts12525-bib-0030" ref-type="ref">30</xref> and <xref rid="cts12525-bib-0031" ref-type="ref">31</xref>).</p>
                    </fn>
                    <fn id="cts12525-tbl3-note-0004">
                      <label>c</label>
                      <p>The rs555754 (r<sup>2</sup> = 0.99 with rs668871) was shown to increase OCT3 messenger RNA expression (ref. <xref rid="cts12525-bib-0029" ref-type="ref">29</xref>).</p>
                    </fn>
                    <fn id="cts12525-tbl3-note-0005">
                      <label>d</label>
                      <p>The rs3745274 is a well‐identified SNP influencing EFV elimination (ref. <xref rid="cts12525-bib-0015" ref-type="ref">15</xref> and <xref rid="cts12525-bib-0028" ref-type="ref">28</xref>).</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>In the multiple linear regression, <italic>ABCC4</italic>_c.*879T&gt;C (rs1059751) was associated with increased ATV CL<sub>u</sub>/F, with no demographics being statistically significant. Decreased RTV CL<sub>u</sub>/F was associated with the mutation at <italic>ABCB1</italic>_c.3435 (rs1045642). BMI remained significant with RTV CL<sub>u</sub>/F. In addition, race was found to be predictive of RTV CL<sub>u</sub>/F; African Americans had significantly lower apparent clearance of RTV than the other populations. Decreased EFV CL<sub>u</sub>/F was related to variants <italic>CYP2B6*6</italic>_15631G&gt;T (rs3745274), <italic>ABCC4</italic>_c.3348A&gt;G/Del (rs1751034), and <italic>ABCC4</italic>_c.*38T&gt;G (rs3742106). Notably, after adjusting for the effects of these SNPs, p16<sup>INK4a</sup> expression was found to be significantly associated with EFV CL<sub>u</sub>/F. A doubling of p16<sup>INK4a</sup> expression was shown to be related to 315 L/h (31% of the median) decrease in EFV unbound CL<sub>u</sub>/F.</p>
                <p>The polymorphisms at <italic>ABCB1</italic>_c.‐129 (rs3213619) and <italic>SLC28A1</italic>_c.1561 (rs2242046) were significantly associated with decreased TFV CL/F, whereas <italic>SLC28A2</italic>_c.531T&gt;C (rs8023604) showed the opposite effect. Creatinine clearance remained significant, whereas age was removed from the model. Sex was related to TFV CL/F after adjusting for gene polymorphism, with women demonstrating lower TFV clearance than men. The <italic>ABCB1</italic>_c.1725+38G&gt;A (rs2235013), <italic>SLC28A2</italic>_c.734G&gt;C (rs10519020), and <italic>ABCC2</italic>_c.3563T&gt;A (rs17222723) were retained in the model for TFV‐DP CL<sub>in</sub>. For FTC CL/F, the significant predictors were <italic>SLC22A3</italic>_c.360C&gt;T&gt;G (rs668871), <italic>SLC22A2</italic>_c.1506A&gt;G (rs316003), <italic>ABCC2</italic>_c.4488C&gt;T (rs8187707), creatinine clearance, and p16<sup>INK4a</sup> expression; the effect of age was eliminated. The <italic>ABCC2</italic>_c.1249G&gt;A (rs2273697) and p16<sup>INK4a</sup> expression were the two significant predictors in the FTC CL<sub>out</sub> linear model. Results from the multiple linear regressions are summarized in <bold>Table</bold>
<xref rid="cts12525-tbl-0005" ref-type="table-wrap">4</xref>.</p>
                <table-wrap id="cts12525-tbl-0005" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 4</label>
                  <caption>
                    <p>Stepwise linear regression analysis</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="char" char="." span="1"/>
                    <col align="char" char="." span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">PK parameters</th>
                        <th align="center" rowspan="1" colspan="1">Factor</th>
                        <th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th>
                        <th align="center" rowspan="1" colspan="1">Effect size</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1">
                          <bold>ATV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*879T&gt;C (MRP4)</td>
                        <td align="char" rowspan="1" colspan="1">0.040<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">151.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>RTV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.3435C&gt;T (P‐gp)</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−855.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">70.21</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Caucasian<xref ref-type="fn" rid="cts12525-tbl4-note-0003">a</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.0027<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">603.1</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Others<xref ref-type="fn" rid="cts12525-tbl4-note-0003">a</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.0036<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">756.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>EFV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*6</italic>_15631G&gt;T (CYP2B6)</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−710.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.3348A&gt;G/Del (MRP4)</td>
                        <td align="char" rowspan="1" colspan="1">0.0020<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−768.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*38T&gt;G (MRP4)</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−845.8</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4</sup>
<xref ref-type="fn" rid="cts12525-tbl4-note-0003">a</xref> expression</td>
                        <td align="char" rowspan="1" colspan="1">0.0083<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−315.2</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.‐129T&gt;C (P‐gp)</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−15.22</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>_c.1561G&gt;A (CNT1)</td>
                        <td align="char" rowspan="1" colspan="1">0.0047<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−12.48</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.531T&gt;C (CNT2)</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">19.18</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">CrCL</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.3220</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Sex – female</td>
                        <td align="char" rowspan="1" colspan="1">0.049<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−6.660s</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV‐DP CL<sub>in</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.1725+38G&gt;A (P‐gp)</td>
                        <td align="char" rowspan="1" colspan="1">0.0031<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−0.0006431</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.734G&gt;C (CNT2)</td>
                        <td align="char" rowspan="1" colspan="1">0.028<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.0026217</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.3563T&gt;A (MRP2)</td>
                        <td align="char" rowspan="1" colspan="1">0.033<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.0006769</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A3</italic>_c.360C&gt;T&gt;G (OCT3)</td>
                        <td align="char" rowspan="1" colspan="1">0.013<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">3.882</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A2</italic>_c.1506A&gt;G (OCT2)</td>
                        <td align="char" rowspan="1" colspan="1">0.019<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">3.860</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.4488C&gt;T (MRP2)</td>
                        <td align="char" rowspan="1" colspan="1">0.0063<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">6.026</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">CrCL</td>
                        <td align="char" rowspan="1" colspan="1">&lt;0.001<xref ref-type="fn" rid="cts12525-tbl5-note-0002">***</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.07060</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4</sup>
<xref ref-type="fn" rid="cts12525-tbl4-note-0003">a</xref> expression</td>
                        <td align="char" rowspan="1" colspan="1">0.034<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">−2.006</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC‐TP CL<sub>out</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.1249G&gt;A (MRP2)</td>
                        <td align="char" rowspan="1" colspan="1">0.022<xref ref-type="fn" rid="cts12525-tbl5-note-0002">*</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.01012</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4</sup>
<xref ref-type="fn" rid="cts12525-tbl4-note-0003">a</xref> expression</td>
                        <td align="char" rowspan="1" colspan="1">0.0090<xref ref-type="fn" rid="cts12525-tbl5-note-0002">**</xref>
</td>
                        <td align="char" rowspan="1" colspan="1">0.008336</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl4-note-0001">
                      <p>ATV, atazanavir; BMI, body mass index; c., chromosome number; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CL<sub>u</sub>/F, apparent unbound drug clearance; CNT, concentrative nucleoside transporter; CrCL, creatinine clearance; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; MRP, multidrug resistance protein; OCT, organic cation transporter; P‐gp, P‐glycoprotein; PK, pharmacokinetic; RTV, ritonavir; TFV, tenofovir; TFV‐DP, tenofovir diphosphate.</p>
                    </fn>
                    <fn id="cts12525-tbl4-note-0002">
                      <p>*<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.01; ***<italic>P</italic> &lt; 0.001.</p>
                    </fn>
                    <fn id="cts12525-tbl4-note-0003">
                      <label>a</label>
                      <p>Reference race: African American; “others” includes other races, unknown races, and unreported races.</p>
                    </fn>
                    <fn id="cts12525-tbl4-note-0004">
                      <p>Note: Only factors that are retained in the final linear regression model are shown in this table. Drug clearance was modeled on the log scale. The expression of p16<sup>INK4a</sup> is presented as logarithm (base 2) of gene expression. Protein names related to the genes are presented in the parentheses.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
              <sec id="cts12525-sec-0150">
                <title>Interaction analysis</title>
                <p>To analyze interactions, we used two distinct linear regression models to determine if there is an interaction effect between chronological age and genetic polymorphisms, and between p16<sup>INK4a</sup> expression and genetic polymorphisms. Most of the significant SNPs in the previous multiple linear regressions were confirmed in this analysis, which was without other demographic variables (<bold>Table</bold>
<xref rid="cts12525-tbl-0006" ref-type="table-wrap">5</xref>). Notably, we found significant evidence of the interaction effects of age and <italic>ABCC4</italic>_c.*879T&gt;C (rs1059751) with ATV CL<sub>u</sub>/F. This effect was also found in the model with p16<sup>INK4a</sup> expression. In addition, both models showed very strong significant evidence of the interaction between age or p16<sup>INK4a</sup> expression and <italic>SLC28A2</italic>_c.734G&gt;C (rs10519020) with TFV‐DP CL<sub>in</sub>.</p>
                <table-wrap id="cts12525-tbl-0006" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 5</label>
                  <caption>
                    <p>Aging‐PGx interaction‐focused linear regression analysis</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">PK parameters</th>
                        <th align="center" rowspan="1" colspan="1">Interaction model with</th>
                        <th align="center" rowspan="1" colspan="1">Factor</th>
                        <th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th>
                        <th align="center" rowspan="1" colspan="1">Q value</th>
                        <th align="center" rowspan="1" colspan="1">Effect size</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>ATV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*879T&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">3.60E‐02</td>
                        <td align="center" rowspan="1" colspan="1">4.02E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−1.33E+03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Age:<italic>ABCC4</italic>_c.*879T&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">2.07E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.77E‐02</td>
                        <td align="center" rowspan="1" colspan="1">3.29E+01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression:<italic>ABCC4</italic>_c.*879T&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">1.44E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.28E‐02</td>
                        <td align="center" rowspan="1" colspan="1">1.18E+02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>RTV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.3435C&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">3.47E‐03</td>
                        <td align="center" rowspan="1" colspan="1">7.32E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−6.29E+02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*1C</italic>_14593C&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">5.75E‐03</td>
                        <td align="center" rowspan="1" colspan="1">1.03E‐02</td>
                        <td align="center" rowspan="1" colspan="1">6.83E+02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.3435C&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">1.63E‐03</td>
                        <td align="center" rowspan="1" colspan="1">6.18E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−6.99E+02</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*1C</italic>_14593C&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">2.07E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.62E‐02</td>
                        <td align="center" rowspan="1" colspan="1">5.71E+02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>EFV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*6</italic>_15631G&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">3.77E‐04</td>
                        <td align="center" rowspan="1" colspan="1">1.19E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−6.92E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*38T&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">4.77E‐04</td>
                        <td align="center" rowspan="1" colspan="1">1.29E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−8.73E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.3348A&gt;G/Del</td>
                        <td align="center" rowspan="1" colspan="1">2.58E‐02</td>
                        <td align="center" rowspan="1" colspan="1">3.06E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−4.94E‐01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="center" rowspan="1" colspan="1">6.60E‐03</td>
                        <td align="center" rowspan="1" colspan="1">1.27E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−2.41E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*6</italic>_15631G&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">3.04E‐04</td>
                        <td align="center" rowspan="1" colspan="1">1.44E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−6.86E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*38T&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">2.48E‐04</td>
                        <td align="center" rowspan="1" colspan="1">1.44E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−8.66E‐01</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.3348A&gt;G/Del</td>
                        <td align="center" rowspan="1" colspan="1">2.79E‐03</td>
                        <td align="center" rowspan="1" colspan="1">6.74E‐03</td>
                        <td align="center" rowspan="1" colspan="1">−8.16E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="center" rowspan="1" colspan="1">2.55E‐07</td>
                        <td align="center" rowspan="1" colspan="1">1.62E‐06</td>
                        <td align="center" rowspan="1" colspan="1">−1.11E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.531T&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">5.95E‐03</td>
                        <td align="center" rowspan="1" colspan="1">1.03E‐02</td>
                        <td align="center" rowspan="1" colspan="1">1.52E+01</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.531T&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">3.94E‐02</td>
                        <td align="center" rowspan="1" colspan="1">4.68E‐02</td>
                        <td align="center" rowspan="1" colspan="1">1.34E+01</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>_c.1561G&gt;A</td>
                        <td align="center" rowspan="1" colspan="1">1.63E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.38E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−1.47E+01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV‐DP CL<sub>in</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.734G&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">8.28E‐10</td>
                        <td align="center" rowspan="1" colspan="1">1.57E‐08</td>
                        <td align="center" rowspan="1" colspan="1">3.58E‐02</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Age: <italic>SLC28A2</italic>_c.734G&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">8.45E‐09</td>
                        <td align="center" rowspan="1" colspan="1">8.03E‐08</td>
                        <td align="center" rowspan="1" colspan="1">−6.20E‐04</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.1725+38G&gt;A</td>
                        <td align="center" rowspan="1" colspan="1">2.19E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.77E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−3.89E‐04</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A2</italic>_c.734G&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">3.29E‐11</td>
                        <td align="center" rowspan="1" colspan="1">6.26E‐10</td>
                        <td align="center" rowspan="1" colspan="1">1.68E‐02</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression: <italic>SLC28A2</italic>_c.734G&gt;C</td>
                        <td align="center" rowspan="1" colspan="1">4.99E‐09</td>
                        <td align="center" rowspan="1" colspan="1">4.74E‐08</td>
                        <td align="center" rowspan="1" colspan="1">−6.14E‐03</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="center" rowspan="1" colspan="1">2.08E‐04</td>
                        <td align="center" rowspan="1" colspan="1">7.91E‐04</td>
                        <td align="center" rowspan="1" colspan="1">−1.65E‐01</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.4488C&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">1.45E‐04</td>
                        <td align="center" rowspan="1" colspan="1">6.90E‐04</td>
                        <td align="center" rowspan="1" colspan="1">6.29E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A2</italic>_c.1506A&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">2.45E‐03</td>
                        <td align="center" rowspan="1" colspan="1">5.83E‐03</td>
                        <td align="center" rowspan="1" colspan="1">3.72E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A3</italic>_c.360C&gt;T/G</td>
                        <td align="center" rowspan="1" colspan="1">1.07E‐02</td>
                        <td align="center" rowspan="1" colspan="1">1.70E‐02</td>
                        <td align="center" rowspan="1" colspan="1">3.11E+00</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="center" rowspan="1" colspan="1">1.86E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.52E‐02</td>
                        <td align="center" rowspan="1" colspan="1">−1.81E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.4488C&gt;T</td>
                        <td align="center" rowspan="1" colspan="1">2.17E‐03</td>
                        <td align="center" rowspan="1" colspan="1">6.74E‐03</td>
                        <td align="center" rowspan="1" colspan="1">6.32E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A2</italic>_c.1506A&gt;G</td>
                        <td align="center" rowspan="1" colspan="1">2.84E‐03</td>
                        <td align="center" rowspan="1" colspan="1">6.74E‐03</td>
                        <td align="center" rowspan="1" colspan="1">4.00E+00</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC22A3</italic>_c.360C&gt;T/G</td>
                        <td align="center" rowspan="1" colspan="1">9.33E‐03</td>
                        <td align="center" rowspan="1" colspan="1">1.61E‐02</td>
                        <td align="center" rowspan="1" colspan="1">3.65E+00</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC‐TP CL<sub>out</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.1249G&gt;A</td>
                        <td align="center" rowspan="1" colspan="1">1.63E‐02</td>
                        <td align="center" rowspan="1" colspan="1">2.38E‐02</td>
                        <td align="center" rowspan="1" colspan="1">1.13E‐02</td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1"/>
                        <td colspan="5" style="border-bottom:solid 1px #000000" align="left" rowspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                        <td align="center" rowspan="1" colspan="1">6.69E‐03</td>
                        <td align="center" rowspan="1" colspan="1">1.27E‐02</td>
                        <td align="center" rowspan="1" colspan="1">9.23E‐03</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl5-note-0001">
                      <p>ATV, atazanavir; c., chromosome number; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CL<sub>u</sub>/F, apparent unbound drug clearance; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; PGx, pharmacogenetics; RTV, ritonavir; TFV, tenofovir; TFV‐DP, tenofovir diphosphate.</p>
                    </fn>
                    <fn id="cts12525-tbl5-note-0002">
                      <p>The <italic>P</italic> values, Q values, and effect sizes shown from interaction models containing gene polymorphisms (single‐nucleotide polymorphisms [SNPs]) and age as factors or SNPs and p16<sup>INK4a</sup> expression as factors. Only factors that were significant after a multiple testing correction at the false discovery rate of q &lt; 0.1 are shown. Drug clearance was modeled on the log scale for drug EFV. The expression of p16<sup>INK4a</sup> is presented as logarithm (base 2) of gene expression.</p>
                    </fn>
                    <fn id="cts12525-tbl5-note-0003">
                      <p>A colon between two variables indicates interaction between the two.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
                <p>In addition to the analysis with traditional statistical approaches, we performed machine learning analysis to evaluate the variable interactions and the overall importance of each of the variables with the PK parameters. Although the Random Forest method did not find consistent interactions, we used it to determine variable importance. The three most important predictors for ATV CL<sub>u</sub>/F were <italic>ABCC4</italic>_c.*879T&gt;C (rs1059751), <italic>SLCO1B1</italic>_c.571T&gt;C, (rs4149057), and sex of the individual. For RTV CL<sub>u</sub>/F, they were <italic>ABCB1</italic>_c.3435C&gt;T (rs1045642), <italic>CYP1A2*1C</italic>_‐3860G&gt;A (rs2069514), and BMI. For EFV CL<sub>u</sub>/F, the three most important variables were <italic>CYP2B6*6</italic>_15631G&gt;T (rs3745274), <italic>ABCC4</italic>_c.3348A&gt;G/Del (rs1751034), and <italic>ABCC4</italic>_c. 311G&gt;A (rs4148551). For TFV they were creatinine clearance, age, and <italic>SLC28A1</italic>_c.1561G&gt;A (rs2242046). For TFV‐DP CL<sub>in</sub>, they were <italic>ABCB1</italic>_c.1725+38G&gt;A (rs2235013), sex, and BMI. For FTC CL/F, they were creatinine clearance, p16<sup>INK4a</sup> expression, and age. For FTC‐TP CL<sub>out</sub>, the three most important predictors were p16<sup>INK4a</sup> expression, <italic>ABCC2</italic>_c.1249G&gt;A (rs2273697), and <italic>SLC28A1</italic>_c.1149A&gt;G (rs2305367). The three most important predictors for each drug are listed in <bold>Table</bold>
<xref rid="cts12525-tbl-0007" ref-type="table-wrap">6</xref>.</p>
                <table-wrap id="cts12525-tbl-0007" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 6</label>
                  <caption>
                    <p>Top three predictors for drug PK in the Random Forest analysis</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1">PK parameters</th>
                        <th align="center" rowspan="1" colspan="1">Top three predictors</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>ATV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.*879T&gt;C (MRP4)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLCO1B1</italic>_c.571T&gt;C (OATP1B1)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Sex</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>RTV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.3435C&gt;T (P‐gp)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP1A2*1C</italic>_‐3860G&gt;A (CYP1A2)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>EFV CL<sub>u</sub>/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>CYP2B6*6</italic>_15631G&gt;T (CYP2B6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c.3348A&gt;G/Del (MRP4)</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC4</italic>_c. 311G&gt;A (MRP4)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>_c.1561G&gt;A (CNT1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">CrCL</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>TFV‐DP CL<sub>in</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCB1</italic>_c.1725+38G&gt;A (P‐gp)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">Sex</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">BMI</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC CL/F</bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1">Age</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">CrCL</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>FTC‐TP CL<sub>out</sub></bold>
                        </td>
                        <td align="left" rowspan="1" colspan="1"><italic>ABCC2</italic>_c.1249G&gt;A (MRP2)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1"><italic>SLC28A1</italic>_c.1149A&gt;G (CNT1)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="left" rowspan="1" colspan="1">p16<sup>INK4a</sup> expression</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="cts12525-tbl6-note-0001">
                      <p>ATV, atazanavir; BMI, body mass index; c., chromosome number; CL/F, apparent clearance; CL<sub>in</sub>, clearance into the cell; CL<sub>out</sub>, clearance out of the cell; CL<sub>u</sub>/F, apparent unbound drug clearance; CNT, concentrative nucleoside transporter; CrCL, creatinine clearance; CYP, cytochrome P450; EFV, efavirenz; F, undetermined bioavailability; FTC, emtricitabine; FTC‐TP, emtricitabine triphosphate; MRP, multidrug resistance protein; OATP, organic anion‐transporting polypeptide; P‐gp, P‐glycoprotein; PK, pharmacokinetic; RTV, ritonavir; TFV, tenofovir; TFV‐DP, tenofovir diphosphate.</p>
                    </fn>
                    <fn id="cts12525-tbl6-note-0002">
                      <p>Drug clearance was modeled on the log scale for drug EFV. The expression of p16<sup>INK4a</sup> is presented as logarithm (base 2) of gene expression. Protein names related to the genes are presented in the parentheses.</p>
                    </fn>
                  </table-wrap-foot>
                  <permissions>
                    <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                  </permissions>
                </table-wrap>
              </sec>
            </sec>
            <sec id="cts12525-sec-0160">
              <title>DISCUSSION</title>
              <p>In this study, we investigated the effects of aging and gene polymorphisms on key PK parameters of five ARVs. Some participant characteristics were significant predictors after adjusting for genetic factors, demonstrating the importance and potential of accounting for PGx in PK analysis. The results from the interaction analysis brought to light interactions between genotype and aging (both chronological and cellular p16<sup>INK4a</sup> expression). The multiple analyses methods used reinforced several of our findings.</p>
              <p>Our analysis showed that increased apparent clearance of unbound ATV is associated with <italic>ABCC4</italic>_c.*879T&gt;C. ATV is highly metabolized in the liver; this variant might lead to decreased efflux<xref rid="cts12525-bib-0032" ref-type="ref">32</xref> of ATV out of the hepatic cells, thus increased ATV metabolism due to accumulation. There is a nominal association with rs4149057 in <italic>SLCO1B1</italic>, the gene that also showed marginal significance in a genomewide association study of ATV PK.<xref rid="cts12525-bib-0033" ref-type="ref">33</xref> Possibly due to limited sample size, our study was not able to detect the UGT1A1 genotype, such as UGT1A1 *28, as a significant predictor of ATV PK.</p>
              <p>The PGx profile of RTV is poorly studied. In our analysis, we found that <italic>ABCB1</italic>_c.3435C&gt;T is significantly associated with decreased CL<sub>u</sub>/F, as previously reported.<xref rid="cts12525-bib-0034" ref-type="ref">34</xref> RTV is a substrate of P‐pg;<xref rid="cts12525-bib-0012" ref-type="ref">12</xref> the presence of variant might increase the bioavailability of RTV, thus decreases the CL<sub>u</sub>/F. In the univariate analysis, <italic>CYP1A2*1C</italic>_‐3860G&gt;A (CYP1A2 *1C, decreased protein function<xref rid="cts12525-bib-0035" ref-type="ref">35</xref>) is associated with decreased RTV CL<sub>u</sub>/F, whereas <italic>CYP2B6</italic>_14593C&gt;G (CYP2B6 *1C, conflicting protein function<xref rid="cts12525-bib-0028" ref-type="ref">28</xref>, <xref rid="cts12525-bib-0035" ref-type="ref">35</xref>) shows the opposite effect. BMI remains a significant predictor and is associated with higher RTV CL<sub>u</sub>/F. Additionally, we found that race plays a role, with African Americans showing the lower RTV clearance than other races. However, the effect of “other” races is not interpretable due to the lack of information of the actual racial background. We found no association between race and the three SNPs mentioned above (data not shown), implying that race might predict RTV CL<sub>u</sub>/F independent of these three SNPs. Our finding suggests that RTV drug disposition is influenced by several factors in a mixed manner, potentially explaining the RTV observed high‐PK variability.</p>
              <p>Our analyses replicated the demonstrated effect of <italic>CYP2B6*6</italic>_15631G&gt;T (rs3745274) to decrease EFV clearance. In addition, we found <italic>ABCC4</italic>_c.3348A&gt;G and <italic>ABCC4</italic>_c.*311G&gt;A, both of which decrease MRP4 function,<xref rid="cts12525-bib-0037" ref-type="ref">37</xref>, <xref rid="cts12525-bib-0038" ref-type="ref">38</xref>, <xref rid="cts12525-bib-0039" ref-type="ref">39</xref> were associated with decreased EFV CL<sub>u</sub>/F. This might be due to increased bioavailability from MRP4 dysfunction. Interestingly, we found that after accounting for these SNPs, decreased EFV CL<sub>u</sub>/F was significantly related to higher p16<sup>INK4a</sup> expression, suggesting that elimination of EFV is associated with cellular aging. The underlying mechanism still needs to be elucidated, although previous work demonstrated that the expression of CYP2B6 is negatively regulated through a CDK2 signaling pathway involving p16<sup>INK4a</sup> in a hepatic carcinoma cell line, HepG2.<xref rid="cts12525-bib-0040" ref-type="ref">40</xref> Our analysis shows that EFV CL<sub>u</sub>/F decreases by 31% of the median with twofold increase in p16<sup>INK4a</sup> expression. Further analysis with larger sample size is needed to validate this finding and inform the potential application of this biomarker to dosing guidance in older HIV‐infected patients.</p>
              <p>The significant SNPs in the univariate analysis independently predict TFV and FTC CL/F, given that all of them are retained in the final model. We found that TFV CL/F is associated with three variants on P‐gp, CNT1, and CNT2, respectively. The <italic>ABCB1</italic>_c.‐129T&gt;C (rs3213619) is shown to decrease CL/F, which might be associated with increased bioavailability through the gut due to decrease P‐gp function.<xref rid="cts12525-bib-0041" ref-type="ref">41</xref> The <italic>SLC28A1</italic>_c.1561G&gt;A (rs2242046) also decreases CL/F, and this may be related to the decreased renal excretion of TFV resulting in increased CNT1 function,<xref rid="cts12525-bib-0042" ref-type="ref">42</xref> which transports more drugs back to the nephrons. There is no information about <italic>SLC28A2</italic>_c.531T&gt;C (rs8023604) function in the literature, but we hypothesize this SNP might decrease CNT2 function, in turn increasing drug excretion to the urine. The three SNPs associated with FTC elimination all increase CL/F. The <italic>SLC22A3</italic>_c.360C&gt;T might be associated with increased OCT3 expression,<xref rid="cts12525-bib-0029" ref-type="ref">29</xref> which increases renal excretion of drugs. The <italic>ABCC2</italic>_c.4488C&gt;T was implicated in one previous study with decreased MRP2 function,<xref rid="cts12525-bib-0030" ref-type="ref">30</xref>, <xref rid="cts12525-bib-0031" ref-type="ref">31</xref> presumably resulting in decreased renal excretion or increased bioavailability, whereas our results indicate the opposite. Additional work will be needed to clarify this finding; no functional information for the <italic>SLC22A2</italic>_c.1506A&gt;G polymorphism is available. In terms of demographics, creatinine clearance is a significant predictor for both TFV and FTC CL/F, and, expectedly, the effect of age was eliminated in multivariate analysis, due to the collinearity of the two variables. However, p16<sup>INK4a</sup> expression was significantly associated with FTC CL/F, but not TFV CL/F; potentially, pathways sensitive to cellular aging might play a role in FTC elimination.</p>
              <p>Cellular uptake of TFV‐DP (CL<sub>in</sub>) is significantly associated with three SNPs on P‐gp, CNT2, and MRP2 genes, respectively. TFV is not a substrate of P‐gp, thus this association might be due to the bioavailability of tenofovir disoproxil fumarate, the prodrug of TFV, during the absorption phase rather than the cellular distribution. The <italic>SLC28A2</italic>_c.734G&gt;C (rs10519020) is shown to increase TFV‐DP CL<sub>in</sub>, implying this SNP may increase CNT2 function. However, there is no known information about this SNP, and the function prediction is the opposite of our finding. The <italic>ABCC2</italic>_c.3563T&gt;A (rs17222723) is related to increased CL<sub>in</sub>, which makes some sense given that this SNP is associated with decreased function of MRP2.<xref rid="cts12525-bib-0030" ref-type="ref">30</xref>, <xref rid="cts12525-bib-0031" ref-type="ref">31</xref> There are some discordant findings regarding the relationship between TFV and MRP2. The study by Ray <italic>et al</italic>.<xref rid="cts12525-bib-0043" ref-type="ref">43</xref> showed that TFV was not substrate of MRP2 using transporter‐overexpressing cell lines. However, some gene association studies showed that <italic>ABCC2</italic> variants were associated with TFV‐induced renal side effects in HIV‐infected patients.<xref rid="cts12525-bib-0044" ref-type="ref">44</xref>, <xref rid="cts12525-bib-0045" ref-type="ref">45</xref> One patient had very high TFV‐DP CL<sub>in</sub> in our studied cohort (408% of the median), potentially driving the significance of this relationship; however, the effects of our significant SNPs on this parameter were independent. FTC‐TP has higher CL<sub>out</sub> from the cells given an <italic>ABCC2</italic>_c.1249G&gt;A variant, which increases MRP2 function.<xref rid="cts12525-bib-0044" ref-type="ref">44</xref>, <xref rid="cts12525-bib-0045" ref-type="ref">45</xref> The p16<sup>INK4a</sup> expression remains a significant predictor, potentially related to effects of cellular aging on the transport of drugs and/or the catabolic and anabolic processes for the metabolites.<xref rid="cts12525-bib-0009" ref-type="ref">9</xref>
</p>
              <p>In the interaction analyses using linear regression models, we saw a significant effect of interaction between aging (both chronological age and p16<sup>INK4a</sup> expression) and gene polymorphism on ATV CL<sub>u</sub>/F and TFV‐DP CL<sub>in</sub>. However, we had two individuals with the <italic>ABCC4</italic> variant in the ATV arm and two individuals with the <italic>SLC28A2</italic> variant in the cohort, limiting the power of the current study. Other demographic variables were not included in the linear regression models, due to the small sample size. Hence, we performed Random Forest analysis that included all the available variables. Random Forest has been shown to have improved power over regression approaches to detect interactions in genetic association studies.<xref rid="cts12525-bib-0046" ref-type="ref">46</xref> However, due to the large number of predictors as compared with the limited sample size, the interaction effects of aging and polymorphisms may have been suppressed by other, stronger predictors in the Random Forest analysis.</p>
              <p>Our study has some limitations. First, the small sample size, especially the ATV/RTV treatment arm, has limited our conclusions. We might have ruled out some important SNPs because of the low allele frequency. The low numbers of participants also compromised the distribution of some studied factors and the statistical power of our analysis; particularly, we lack participants with the frailty phenotype, limiting our ability to investigate frailty. Second, due to the large number of variables, we conducted the interaction analysis only involving aging (both chronological and cellular) and genetic factors, potentially excluding the interaction of other demographic factors with genetic factors. The interaction analyses were limited by low numbers of the minor alleles for the SNPs studied. The estimated effect sizes should be used to motivate well‐powered follow‐up studies to work to establish genetic factors as potential PK predictors.</p>
              <p>Nevertheless, our study has several advantages. Using a novel statistical methodology, a population PK model is able to describe the PK processes more physiologically and explain the variability associated with those processes more appropriately than traditional PK analysis. Therefore, our analysis is based on more precise PK parameters, partially compensating for the small sample size. Additionally, we explored the SNPs at a gene‐wide level with the DMET array platform, maximizing the chance to identify relevant SNPs/genes. We found the associations of several SNPs with ARV PK that have not been reported before, generating interesting hypotheses for future study. Moreover, we evaluated the interaction between aging and SNPs in predicting ARV PK, using both the chronological and cellular aging. The significant interactions between aging and the genetic factors were seen for both chronological age and p16<sup>INK4a</sup> expression.</p>
              <p>Our study provides data on the effect of aging on ARVs PK in the context of PGx, highlighting the importance of the cellular aging biomarker, p16<sup>INK4a</sup>, in predicting the ARV drug disposition and the potential alterations in aging‐PK relations by PGx. The investigations add knowledge to the current PGx of ARVs, and facilitate further studies with focus on precision treatments, especially those containing drugs with similar disposition profiles with our studied ARVs, for the growing older HIV‐infected population.</p>
            </sec>
            <sec id="cts12525-sec-0200">
              <title>Conflict of Interest</title>
              <p>The authors declared no conflict of interest.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data">
                <caption>
                  <p>Supporting Information</p>
                </caption>
                <media xlink:href="CTS-11-226-s001.csv">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data">
                <caption>
                  <p>Supporting Information</p>
                </caption>
                <media xlink:href="CTS-11-226-s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="cts12525-sec-0170">
              <title>Acknowledgments</title>
              <p>The authors wish to thank the participants and study team of the original clinical study IRB 09–2120 from the University of North Carolina Clinical and Translational Research Center (UL1RR02574), the University of North Carolina Health Care Infectious Diseases Clinic, and the Cone Health Regional Center for Infectious Diseases. We also acknowledge the analytical team from Gentris Company (Morrisville, NC) for performing the DMET chip array analysis.</p>
            </ack>
            <ack id="cts12525-sec-0180">
              <title>Source of Funding</title>
              <p>The work was supported in part by funding from the National Center for Advancing Translational Sciences (NCATS), (UL1RR02574), National Institutes of Health, through Grant Award Number UL1TR001111 and the National Institute of Allergy and Infectious Diseases (K23 AI093156, awarded to J.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
            </ack>
            <ack id="cts12525-sec-0190">
              <title>Author Contributions</title>
              <p>J.C., F.A., and J.D. wrote the manuscript. J.D. designed the research. J.C. and J.D. performed the research. J.C., F.A., M.W., O.S., and A.M.‐R. analyzed the data. T.W. contributed new reagents/analytical tools.</p>
            </ack>
            <ref-list id="cts12525-bibl-0001">
              <ref id="cts12525-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0001"><string-name><surname>Calcagno</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cusato</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>D'Avolio</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Bonora</surname>, <given-names>S.</given-names></string-name>
<article-title>Genetic polymorphisms affecting the pharmacokinetics of antiretroviral drugs</article-title>. <source>Clin. Pharmacokinet</source>. <volume>56</volume>, <fpage>355</fpage>–<lpage>369</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">27641153</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0002"><string-name><surname>Olagunju</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Owen</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Cressey</surname>, <given-names>T.R.</given-names></string-name>
<article-title>Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding</article-title>. <source>Pharmacogenomics</source>
<volume>13</volume>, <fpage>1501</fpage>–<lpage>1522</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23057550</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0003"><string-name><surname>Pinillos</surname>, <given-names>F.</given-names></string-name><italic>et al</italic><article-title>Case report: Severe central nervous system manifestations associated with aberrant efavirenz metabolism in children: the role of CYP2B6 genetic variation</article-title>. <source>BMC Infect. Dis</source>. <volume>16</volume>, <fpage>56</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26831894</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="miscellaneous" id="cts12525-cit-0004"><collab collab-type="authors">UNAIDS Report. People aged 50 years and older</collab>
. <ext-link ext-link-type="uri" xlink:href="http://www.unaids.org/en/resources/documents/2014/Peopleaged50yearsandolder">http://www.unaids.org/en/resources/documents/2014/Peopleaged50yearsandolder</ext-link> (<year>2014</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="miscellaneous" id="cts12525-cit-0005"><article-title>Centers for Disease Control and Prevention (CDC). HIV among people aged 50 and over</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/hiv/group/age/olderamericans/index.html">https://www.cdc.gov/hiv/group/age/olderamericans/index.html</ext-link> (<year>2015</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0006"><string-name><surname>Smit</surname>, <given-names>M.</given-names></string-name><italic>et al</italic><article-title>Future challenges for clinical care of an ageing population infected with HIV: a modelling study</article-title>. <source>Lancet Infect. Dis</source>. <volume>15</volume>, <fpage>810</fpage>–<lpage>818</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26070969</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0007"><string-name><surname>Schoen</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Erlandson</surname>, <given-names>K.M.</given-names></string-name> &amp; <string-name><surname>Anderson</surname>, <given-names>P.L.</given-names></string-name>
<article-title>Clinical pharmacokinetics of antiretroviral drugs in older persons</article-title>. <source>Expert Opin. Drug Metab. Toxicol</source>. <volume>9</volume>, <fpage>573</fpage>–<lpage>588</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23514375</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0008"><string-name><surname>Dumond</surname>, <given-names>J.B.</given-names></string-name><italic>et al</italic><article-title>Population pharmacokinetics modeling of unbound efavirenz, atazanavir, and ritonavir in HIV‐infected subjects with aging biomarkers.</article-title><source>CPT Pharmacometrics Syst. Pharmacol.</source><volume>6</volume>, <fpage>128</fpage>–<lpage>135</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28032946</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0009"><string-name><surname>Dumond</surname>, <given-names>J.B.</given-names></string-name><italic>et al</italic><article-title>p16INK4a, a senescence marker, influences tenofovir/emtricitabine metabolite disposition in HIV‐infected subjects</article-title>. <source>CPT Pharmacometrics Syst. Pharmacol.</source><volume>6</volume>, <fpage>120</fpage>–<lpage>127</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28019088</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0010"><string-name><surname>Waade</surname>, <given-names>R B.</given-names></string-name>, <string-name><surname>Hermann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Moe</surname>, <given-names>H.L.</given-names></string-name> &amp; <string-name><surname>Molden</surname>, <given-names>E.</given-names></string-name>
<article-title>Impact of age on serum concentrations of venlafaxine and escitalopram in different CYP2D6 and CYP2C19 genotype subgroups</article-title>. <source>Eur. J. Clin. Pharmacol.</source>
<volume>70</volume>, <fpage>933</fpage>–<lpage>940</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24858822</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0011"><collab collab-type="authors">Bristol‐Myers Squibb Company</collab>
. <article-title>Reyataz (atazanavir)</article-title>. <source>Full U.S. prescribing information</source>. https://packageinserts.bms.com/pi/pi_reyataz.pdf (<year>2017</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0012"><collab collab-type="authors">AbbVie Inc</collab>
. <article-title>Norvir (ritonavir) Tablets</article-title>. <source>Full U.S. prescribing information</source>. <ext-link ext-link-type="uri" xlink:href="http://norvir.com/">http://norvir.com/</ext-link> (<year>2017</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0013"><string-name><surname>Schipani</surname>, <given-names>A.</given-names></string-name><italic>et al</italic><article-title>Population pharmacokinetic modeling of the association between 63396C‐&gt;T pregnane X receptor polymorphism and unboosted atazanavir clearance.</article-title><source>Antimicrob. Agents Chemother.</source><volume>54</volume>, <fpage>5242</fpage>–<lpage>5250</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20921307</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0014"><string-name><surname>Bonora</surname>, <given-names>S.</given-names></string-name><italic>et al</italic><article-title>Successful pharmacogenetics‐based optimization of unboosted atazanavir plasma exposure in HIV‐positive patients: a randomized, controlled, pilot study (the REYAGEN study).</article-title><source>J. Antimicrob. Chemother.</source><volume>70</volume>, <fpage>3096</fpage>–<lpage>3099</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26174719</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="miscellaneous" id="cts12525-cit-0015"><article-title>PharmGKB. Efavirenz overview |</article-title>. <ext-link ext-link-type="uri" xlink:href="https://www.pharmgkb.org/">https://www.pharmgkb.org/</ext-link> (<year>2017</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0016"><collab collab-type="authors">Bristol‐Myers Squibb Company</collab>
. <article-title>Sustiva (efavirenz)</article-title>. <source>Full U.S. prescribing information</source>. <ext-link ext-link-type="uri" xlink:href="https://packageinserts.bms.com/pi/pi_sustiva.pdf">https://packageinserts.bms.com/pi/pi_sustiva.pdf</ext-link> (<year>2017).</year>
</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0017"><string-name><surname>Kis</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Robillard</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>G.N.</given-names></string-name> &amp; <string-name><surname>Bendayan</surname>, <given-names>R.</given-names></string-name>
<article-title>The complexities of antiretroviral drug‐drug interactions: role of ABC and SLC transporters</article-title>. <source>Trends Pharmacol. Sci</source>. <volume>31</volume>, <fpage>22</fpage>–<lpage>35</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20004485</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0018"><string-name><surname>Purcell</surname>, <given-names>S.</given-names></string-name><italic>et al</italic><article-title>PLINK: a tool set for whole‐genome association and population‐based linkage analyses</article-title>. <source>Am. J. Hum. Genet</source>. <volume>81</volume>, <fpage>559</fpage>–<lpage>575</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17701901</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0019"><string-name><surname>Howie</surname>, <given-names>B.N.</given-names></string-name>, <string-name><surname>Donnelly</surname>, <given-names>P.</given-names></string-name> &amp; <string-name><surname>Marchini</surname>, <given-names>J.</given-names></string-name>
<article-title>A flexible and accurate genotype imputation method for the next generation of genome‐wide association studies</article-title>. <source>PLoS Genet</source>. <volume>5</volume>, <fpage>e1000529</fpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19543373</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0020"><string-name><surname>Howie</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Marchini</surname>, <given-names>J.</given-names></string-name> &amp; <string-name><surname>Stephens</surname>, <given-names>M.</given-names></string-name>
<article-title>Genotype imputation with thousands of genomes</article-title>. <source>G3 (Bethesda)</source>
<volume>1</volume>, <fpage>457</fpage>–<lpage>470</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">22384356</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0021"><collab collab-type="authors">R Development Core Team</collab>
. <article-title>R: a language and environment for statistical computing.</article-title>
<source>R Foundation for Statistical Computing, Vienna Austria</source>. (<year>2016</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0022"><string-name><surname>Liaw</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Wiener</surname>, <given-names>M.</given-names></string-name>
<article-title>Classification and regression by randomForest</article-title>. <source>R News</source>
<volume>2</volume>, <fpage>18</fpage>–<lpage>22</lpage> (<year>2002</year>).</mixed-citation>
              </ref>
              <ref id="cts12525-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0023"><string-name><surname>Chelala</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Khan</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Lemoine</surname>, <given-names>N.R.</given-names></string-name>
<article-title>SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms</article-title>. <source>Bioinformatics</source>
<volume>25</volume>, <fpage>655</fpage>–<lpage>661</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19098027</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0024"><string-name><surname>Dayem Ullah</surname>, <given-names>A.Z.</given-names></string-name>, <string-name><surname>Lemoine</surname>, <given-names>N.R.</given-names></string-name> &amp; <string-name><surname>Chelala</surname>, <given-names>C.</given-names></string-name>
<article-title>SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update)</article-title>. <source>Nucleic Acids Res</source>. <volume>40</volume> (Web Server issue), <fpage>W65</fpage>–<lpage>W70</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22544707</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0025"><string-name><surname>Dayem Ullah</surname>, <given-names>A.Z.</given-names></string-name>, <string-name><surname>Lemoine</surname>, <given-names>N.R.</given-names></string-name> &amp; <string-name><surname>Chelala</surname>, <given-names>C.</given-names></string-name>
<article-title>A practical guide for the functional annotation of genetic variations using SNPnexus</article-title>. <source>Brief Bioinform.</source>
<volume>14</volume>, <fpage>437</fpage>–<lpage>447</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23395730</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0026"><string-name><surname>Ward</surname>, <given-names>L.D.</given-names></string-name> &amp; <string-name><surname>Kellis</surname>, <given-names>M.</given-names></string-name>
<article-title>HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants</article-title>. <source>Nucleic Acids Res</source>. <volume>40</volume> (Database issue) <fpage>D930</fpage>–<lpage>D934</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22064851</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0027"><string-name><surname>Fried</surname>, <given-names>L.P.</given-names></string-name><italic>et al</italic><article-title>Frailty in older adults: evidence for a phenotype.</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci.</source><volume>56</volume>, <fpage>M146</fpage>–<lpage>M156</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11253156</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0028"><string-name><surname>Holzinger</surname>, <given-names>E.R.</given-names></string-name><italic>et al</italic><article-title>Genome‐wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants</article-title>. <source>Pharmacogenet. Genomics</source><volume>22</volume>, <fpage>858</fpage>–<lpage>867</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23080225</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0029"><string-name><surname>Chen</surname>, <given-names>L.</given-names></string-name><italic>et al</italic><article-title>Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3.</article-title><source>Pharmacogenomics J</source>. <volume>13</volume>, <fpage>110</fpage>–<lpage>120</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">22231567</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0030"><string-name><surname>Elens</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yombi</surname>, <given-names>J.C.,</given-names></string-name><string-name><surname>Lison</surname>, <given-names>D.</given-names></string-name><string-name><surname>Wallemacq</surname>, <given-names>P.</given-names></string-name><string-name><surname>Vandercam</surname>, <given-names>B. &amp;</given-names></string-name><string-name><surname>Haufroid</surname>, <given-names>V.</given-names></string-name><article-title>Association between ABCC2 polymorphism and lopinavir accumulation in peripheral blood mononuclear cells of HIV‐infected patients</article-title>. <source>Pharmacogenomics</source><volume>10</volume>, <fpage>1589</fpage>–<lpage>1597</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19842932</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0031"><string-name><surname>Elens</surname>, <given-names>L.</given-names></string-name><italic>et al</italic><article-title>Functional defect caused by the 4544G&gt;A SNP in ABCC2: potential impact for drug cellular disposition</article-title>. <source>Pharmacogenet. Genomics</source><volume>21</volume>, <fpage>884</fpage>–<lpage>893</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">22027652</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0032"><string-name><surname>Likanonsakul</surname>, <given-names>S.</given-names></string-name><italic>et al</italic><article-title>A single‐nucleotide polymorphism in ABCC4 is associated with tenofovir‐related beta2‐microglobulinuria in Thai patients with HIV‐1 infection.</article-title><source>PLoS One</source><volume>11</volume>, <fpage>e0147724</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26807589</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0033"><string-name><surname>Johnson</surname>, <given-names>D.H.</given-names></string-name><italic>et al</italic><article-title>Genomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202.</article-title><source>Pharmacogenet. Genomics</source><volume>24</volume>, <fpage>195</fpage>–<lpage>203</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24557078</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0034"><string-name><surname>Anderson</surname>, <given-names>P.L.</given-names></string-name><italic>et al</italic><article-title>Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non‐expressors.</article-title><source>J. Antimicrob. Chemother.</source><volume>64</volume>, <fpage>1071</fpage>–<lpage>1079</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19710077</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0035"><string-name><surname>Thorn</surname>, <given-names>C.F.</given-names></string-name>, <string-name><surname>Aklillu</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Klein</surname>, <given-names>T.E.</given-names></string-name> &amp; <string-name><surname>Altman</surname>, <given-names>R.B.</given-names></string-name>
<article-title>PharmGKB summary: very important pharmacogene information for CYP1A2.</article-title>
<source>Pharmacogenet. Genomics</source>
<volume>22</volume>, <fpage>73</fpage>–<lpage>77</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">21989077</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0036"><string-name><surname>Mega</surname>, <given-names>J.L.</given-names></string-name><italic>et al</italic><article-title>Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes</article-title>. <source>Circulation</source><volume>119</volume>, <fpage>2553</fpage>–<lpage>2560</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19414633</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0037"><string-name><surname>Kiser</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Aquilante</surname>, <given-names>C.L.,</given-names></string-name><string-name><surname>Anderson</surname>, <given-names>P.L.,</given-names></string-name><string-name><surname>King</surname>, <given-names>T.M.,</given-names></string-name><string-name><surname>Carten</surname>, <given-names>M.L. &amp;</given-names></string-name><string-name><surname>Fletcher</surname>, <given-names>C.V.</given-names></string-name><article-title>Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV‐infected patients</article-title>. <source>J. Acquir. Immune Defic. Syndr</source>. <volume>47</volume>, <fpage>298</fpage>–<lpage>303</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18398970</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0038"><string-name><surname>Sánchez</surname>, <given-names>A.</given-names></string-name><italic>et al</italic><article-title>Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV‐infected patients</article-title>. <source>Antimicrob. Agents Chemother</source>. <volume>55</volume>, <fpage>5314</fpage>–<lpage>5324</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21896912</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0039"><string-name><surname>Rungtivasuwan</surname>, <given-names>K.</given-names></string-name><italic>et al</italic><article-title>Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV‐infected patients.</article-title><source>Antimicrob. Agents Chemother.</source><volume>59</volume>, <fpage>3240</fpage>–<lpage>3245</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25801567</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0040"><string-name><surname>Sugatani</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Osabe</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kurosawa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Kitamura</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ikari</surname>, <given-names>A.</given-names></string-name> &amp; <string-name><surname>Miwa</surname>, <given-names>M.</given-names></string-name>
<article-title>Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin‐dependent kinase 2 activity: cell cycle‐dependent expression.</article-title>
<source>Drug Metab. Dispos.</source>
<volume>38</volume>, <fpage>177</fpage>–<lpage>186</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">19797611</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0041"><string-name><surname>Abraham</surname>, <given-names>J.E.</given-names></string-name><italic>et al</italic><article-title>Replication of genetic polymorphisms reported to be associated with taxane‐related sensory neuropathy in patients with early breast cancer treated with paclitaxel.</article-title><source>Clin. Cancer Res.</source><volume>20</volume>, <fpage>2466</fpage>–<lpage>2475</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24599932</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0042"><string-name><surname>Gray</surname>, <given-names>J.H.</given-names></string-name><italic>et al</italic><article-title>Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.</article-title><source>Mol. Pharmacol.</source><volume>65</volume>, <fpage>512</fpage>–<lpage>519</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">14978229</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0043"><string-name><surname>Ray</surname>, <given-names>A.S.</given-names></string-name><italic>et al</italic><article-title>Mechanism of active renal tubular efflux of tenofovir</article-title>. <source>Antimicrob. Agents Chemother</source>. <volume>50</volume>, <fpage>3297</fpage>–<lpage>3304</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">17005808</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0044"><string-name><surname>Izzedine</surname>, <given-names>H.</given-names></string-name><italic>et al</italic><article-title>Association between ABCC2 gene haplotypes and tenofovir‐induced proximal tubulopathy.</article-title><source>J. Infect. Dis.</source><volume>194</volume>, <fpage>1481</fpage>–<lpage>1491</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">17083032</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0045"><string-name><surname>Dahlin</surname>, <given-names>A.</given-names></string-name><italic>et al</italic><article-title>A pharmacogenetic candidate gene study of tenofovir‐associated Fanconi syndrome</article-title>. <source>Pharmacogenet. Genomics</source><volume>25</volume>, <fpage>82</fpage>–<lpage>92</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25485598</pub-id></mixed-citation>
              </ref>
              <ref id="cts12525-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="cts12525-cit-0046"><string-name><surname>Motsinger</surname>, <given-names>A.A.</given-names></string-name>, <string-name><surname>Ritchie</surname>, <given-names>M.D.</given-names></string-name> &amp; <string-name><surname>Reif</surname>, <given-names>D.M.</given-names></string-name>
<article-title>Novel methods for detecting epistasis in pharmacogenomics studies</article-title>. <source>Pharmacogenomics</source>
<volume>8</volume>, <fpage>1229</fpage>–<lpage>1241</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17924838</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
